April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
IL-10 Inhibits Early Events in Angiogenesis
Author Affiliations & Notes
  • D. Reis
    College of Biomedical Science,
    Florida Atlantic University, Boca Raton, Florida
  • J. Simon
    College of Biomedical Science,
    Florida Atlantic University, Boca Raton, Florida
  • P. G. Mascaro
    College of Biomedical Science,
    Florida Atlantic University, Boca Raton, Florida
  • J. Pearsall
    College of Biomedical Science,
    Florida Atlantic University, Boca Raton, Florida
  • J. C. Blanks
    College of Science,
    Florida Atlantic University, Boca Raton, Florida
  • Y. Shibata
    College of Biomedical Science,
    Florida Atlantic University, Boca Raton, Florida
  • C. K. Dorey
    College of Biomedical Science,
    Florida Atlantic University, Boca Raton, Florida
  • Footnotes
    Commercial Relationships  D. Reis, None; J. Simon, None; P.G. Mascaro, None; J. Pearsall, None; J.C. Blanks, None; Y. Shibata, None; C.K. Dorey, None.
  • Footnotes
    Support  Funds from FAU College of Biomedical Science (CKD) and NIH grant 1R15EY018947-01 (CKD)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5690. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. Reis, J. Simon, P. G. Mascaro, J. Pearsall, J. C. Blanks, Y. Shibata, C. K. Dorey; IL-10 Inhibits Early Events in Angiogenesis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5690.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : In the murine model of oxygen-induced retinopathy (OIR), we previously reported that intravitreal IL-10, administered on P12 as mice were transferred to room air, caused strong selective inhibition of neovascularization (NV) at P17 without an effect on intraretinal angiogenesis. Because IL-10 has a short half-life, we hypothesized that the IL-10 effects were mediated by its well-known suppression of macrophage (MΦ) recruitment and expression of inflammatory cytokines (e.g. IL-1, IL-6, TNF, and MCP-1), and further, that these cytokines contribute to early pathological NV. However, others have reported that higher doses of IL-10 stimulate NV in the OIR model. To better understand the effect of IL-10 on early events in angiogenesis, we examined VEGF-dependent microvessel formation in aortic rings, in which early angiogenesis is enhanced by MΦ cytokines (Gelati et al, 2008).

Methods: : Aortic rings were prepared from the ascending aorta of ~2 month old mice and fed every 48 hrs with control media (MCDB131 + 20 ng VEGF/ml +2.5% FBS) or control media + IL-10 (25, 50, 125, 250, 500 or 2000 ng/ml). Microvessels were counted at day 7 or 10. IL-10 signal transduction is mediated by heme oxygenase (HO-1)-dependent generation of carbon monoxide, which has both proangiogenic and anti-inflammatory effects. Therefore, we also examined the effect of an HO-1 substrate (2.5 µM hemin) on the IL-10 response. Statistical comparisons were made with Student's t-tests.

Results: : Angiogenesis was inhibited 25% (P=0.1) at 2 µg IL-10/ml (approximately equal to intravitreal injection of 10 ng IL-10). However, IL-10 at 25-500 ng/ml had no significant effect on microvessel formation. Hemin alone had no effect on angiogenesis, but hemin plus 50 ng IL-10 /ml caused 50% inhibition (P<0.01).

Conclusions: : IL-10 significantly inhibits early events in inflammatory-mediated angiogenesis, and this response is dependent on heme-oxygenase activity. The failure to detect a proangiogenic effect of IL-10 may relate to the concurrent exposure to VEGF in both the aortic ring assay, and in the retina in the OIR model. These results suggest that the role of IL-10 in the OIR model deserves further study.

Keywords: neovascularization • inflammation • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×